Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1303
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04341311 | Phase I Study of Marizomib + Panobinostat for Children With DIPG | ||
| NCT00131014 | Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies | ||
| NCT05327452 | Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study | ||
| NCT00116506 | Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer | ||
| NCT00207636 | Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening | ||
| NCT01167114 | STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer | ||
| NCT04606316 | Surgical Nivolumab And Ipilimumab For Recurrent GBM | ||
| NCT02207504 | Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer | ||
| NCT06950307 | Hypofractionation for Prostate Cancer in Africa: A Feasibility Study | ||
| NCT00358163 | Trial of PTK787/ZK 222584 Plus Paclitaxel | ||
| NCT00148707 | Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | ||
| NCT00418093 | Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma | ||
| NCT00006106 | ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer | ||
| NCT05934448 | Pembro Plus CAR T-cell Therapy in R/R in PMBCL | ||
| NCT04724018 | Sacituzumab Govitecan Plus EV in Metastatic UC | ||
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | ||
| NCT00058487 | Epirubicin and Thalidomide in Treating Patients With Liver Cancer | ||
| NCT06366347 | ALPINE: Maintenance Letrozole/Abemaciclib | ||
| NCT00095836 | Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy | ||
| NCT04947917 | Axillary Lymph Node Tattoo Marking Study | ||
| NCT06722014 | Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanced Cancers | ||
| NCT04691297 | Digitally Enhanced Smoking Cessation for High Risk Smokers | ||
| NCT02251548 | A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia | ||
| NCT04899908 | Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases | ||
| NCT00136448 | High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML) | ||
| NCT00487305 | Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma | ||
| NCT02852655 | A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma | ||
| NCT01250717 | Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer | ||
| NCT00369226 | Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation | ||
| NCT06239220 | PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC | ||
| NCT02137252 | Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer | ||
| NCT00148655 | Educational Interventions for Patients With DCIS | ||
| NCT00308178 | Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer | ||
| NCT06736548 | Sleep Treatment Education Program for Cancer Survivors: STEP-Together | ||
| NCT06422455 | Access to Genetic Testing in Underserved Patients With Cancer | ||
| NCT07101458 | The Eswatini PRISM Study on Adolescents Living With HIV | ||
| NCT01982448 | Cisplatin vs Paclitaxel for Triple Negative Breast Cancer | ||
| NCT00593060 | Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer | ||
| NCT01494662 | HKI-272 for HER2-Positive Breast Cancer and Brain Metastases | ||
| NCT02958969 | Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma | ||
| NCT00095927 | Randomized Amifostine For SCCHN | ||
| NCT04115254 | Stereotactic Magnetic Resonance Guided Radiation Therapy | ||
| NCT00438854 | Dasatinib in Relapsed Chronic Lymphocytic Leukemia | ||
| NCT01965353 | A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma | ||
| NCT04789486 | Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer | ||
| NCT02118987 | Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization | ||
| NCT06117709 | Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing | ||
| NCT00657267 | Dose-Intense Temozolomide in Recurrent Glioblastoma | ||
| NCT03675893 | RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer | ||
| NCT00458536 | Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF |
